Skip to main content
. 2022 Jan 22;14(3):557. doi: 10.3390/cancers14030557

Table 2.

Patient characteristics.

Variable Before 223Ra Before RLT
PSA (ng/mL) 35.2 (15.9–147) 161 (76–336)
Hemoglobin (g/L) 13.6 (12.6–14.3) 12.1 (11.2–13.3)
White blood cells (109/L) 5.5 (4.6–7.4) 5.2 (4.0–7.0)
Platelets (109/L) 192 (224–276) 189 (169–240)
Sites of metastases
Bone
-oligofocal/multifocal 18 (64) 16 (57)
-disseminiated/diffuse 10 (36) 12 (43)
Local recurrence 3 (11) 8 (29)
Lymph nodes 16 (57) 20 (71)
Visceral 0 (0) 3 (11)

Data presented as median with interquartile range (IQR) or n (%), PSA: prostate-specific antigen.